Immunopharmacology of CpG DNA
Authors:
- S. ZimmermannSZS. Zimmermann
- K. HeegKHK. Heeg
- 6 January 2002
- journal article
- review article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 383 (10) , 1491-1500
Abstract
Recognition of danger of infection by innate immune cells is a prerequisite to combat infections and to activate T and B cells. Pathogen-associated molecular patterns (PAMP) play a fundamental role in this process. PAMPs are sensed by at least ten different Toll-like receptors (TLR). Within the realm of PAMPs, CpG DNA that is recognized by TLR-9 has an outstanding propensity to induce a milieu that favors activation of T lymphocytes and biases Th1-dominated immune responses. Therefore CpG DNA has become a promising immuno-therapeutical candidate to assist and to direct immune responses such as in vaccination or modulation of allergic responses. As opposed to other PAMPs, CpG DNA can be synthesized with defined purity and base composition. Moreover, chemical substitutions can confer new qualities to synthetic CpG DNA.Keywords
This publication has 39 references indexed in Scilit:
- Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivoImmunology, 2002
- Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12European Journal of Immunology, 2001
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- RETRACTED: DNA-PKcs Is Required for Activation of Innate Immunity by Immunostimulatory DNACell, 2000
- Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Immunostimulatory DNA: Sequence‐dependent production of potentially harmful or useful cytokinesEuropean Journal of Immunology, 1997
- CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvantsEuropean Journal of Immunology, 1997
- Bacterial DNA causes septic shockNature, 1997
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virusLife Sciences, 1994